AU2003260033A1 - Methods of treating acute respiratory distress syndrome - Google Patents

Methods of treating acute respiratory distress syndrome

Info

Publication number: AU2003260033A1
Authority: AU; Australia
Prior art keywords: methods; respiratory distress; distress syndrome; acute respiratory; treating acute
Prior art date: 2002-08-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003260033A

Inventor

John F. Parkinson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee

Schering AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-29

Filing date

2003-08-22

Publication date

2004-03-19

2003-08-22 Application filed by Schering AG filed Critical Schering AG

2004-03-19 Publication of AU2003260033A1 publication Critical patent/AU2003260033A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003260033A 2002-08-29 2003-08-22 Methods of treating acute respiratory distress syndrome Abandoned AU2003260033A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US40673902P	2002-08-29	2002-08-29
US60/406,739		2002-08-29
PCT/US2003/026462 WO2004019986A1 (en)	2002-08-29	2003-08-22	Methods of treating acute respiratory distress syndrome

Publications (1)

Publication Number	Publication Date
AU2003260033A1 true AU2003260033A1 (en)	2004-03-19

Family

ID=31978349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003260033A Abandoned AU2003260033A1 (en)	2002-08-29	2003-08-22	Methods of treating acute respiratory distress syndrome

Country Status (2)

Country	Link
AU (1)	AU2003260033A1 (en)
WO (1)	WO2004019986A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005311985A1 (en) *	2004-12-01	2006-06-08	Kalypsys, Inc.	Inducible nitric oxide synthase dimerization inhibitors
EP2240026A4 (en) *	2008-01-30	2011-10-19	Glaxosmithkline Llc	NOVEL sEH INHIBITORS AND THEIR USE
WO2009097474A1 (en) *	2008-01-30	2009-08-06	Smithkline Beecham Corporation	Novel seh inhibitors and their use
US9701661B2 (en) *	2014-07-11	2017-07-11	Northwestern University	2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL131475A0 (en) *	1997-02-19	2001-01-28	Berlex Lab	N-heterocyclic derivatives as nos inhibitors
US6432947B1 (en) *	1997-02-19	2002-08-13	Berlex Laboratories, Inc.	N-heterocyclic derivatives as NOS inhibitors
SE9701304D0 (en) *	1997-04-09	1997-04-09	Astra Pharma Prod	Compounds
SE9802333D0 (en) *	1998-06-29	1998-06-29	Astra Pharma Prod	Novel combination
EP1448515A2 (en) *	2001-11-29	2004-08-25	Theracos, Inc.	Compounds for treatment of inflammation, diabetes and related disorders

2003
- 2003-08-22 AU AU2003260033A patent/AU2003260033A1/en not_active Abandoned
- 2003-08-22 WO PCT/US2003/026462 patent/WO2004019986A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004019986A1 (en)	2004-03-11

Similar Documents

Publication	Publication Date	Title
AU2003293345A1 (en)	2004-06-23	Detection of disordered breathing
AU2003247483A1 (en)	2003-12-31	Methods for treatment of acute lymphocytic leukemia
AU2003218169A8 (en)	2003-09-29	Method for the purification, production and formulation of oncolytic adenoviruses
AU2003293333A1 (en)	2004-06-23	Method of treating cancers
AU2003247624A1 (en)	2004-01-06	Method of treating the syndrome of lipodystrophy
AU2001285747A1 (en)	2003-02-06	Method for the treatment of tobacco
AU2002354439A1 (en)	2004-06-30	Nanocarbon-dissolving aqueous solution, aqueous solution for purification, and method of purification
AU2002359950A1 (en)	2003-07-24	Plasma treatment method
AU2003277596A1 (en)	2004-07-29	Method of deuterization
AU2003275056A1 (en)	2004-04-08	Novel lapacho compounds and methods of use thereof
AU2002367010A1 (en)	2003-07-30	Method of purifying brine
IL164078A0 (en)	2005-12-18	Treatment of lung disorder
AU2003222120A1 (en)	2003-10-13	Oxon process
AU2003233820A1 (en)	2003-12-02	Method for the treatment of starch
AU2003260033A1 (en)	2004-03-19	Methods of treating acute respiratory distress syndrome
AU2003286456A1 (en)	2004-05-04	Method of purification of carbon dioxide
AUPR381601A0 (en)	2001-04-12	Method of treating respiratory conditions
AU2002951913A0 (en)	2002-10-24	Method of treatment
GB0208897D0 (en)	2002-05-29	New method of treatment
GB0217493D0 (en)	2002-09-04	Novel methods of treatment
GB0221712D0 (en)	2002-10-30	Methods of treatment
AU2003209534A1 (en)	2003-09-22	The method of treating tuberculosis
GB0213198D0 (en)	2002-07-17	Method of treatment
AU2003244633A1 (en)	2004-01-23	Methods for the treatment of sinusitis
AUPS219902A0 (en)	2002-06-06	Methods of treatment

Legal Events

Date	Code	Title	Description
2005-05-26	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase